NEW: Listen to Fraser McEwen from TC Alternatives discuss the Opportunity in Mass Torts here
The Fund will provide investors with direct access to the mass tort market, and aims to generate uncorrelated and compelling risk adjusted returns, supported by proprietary technology, deep legal partnerships, and transparent fund management.
The TC Alternatives Litigation Fund seeks to provide qualified investors with structured exposure to the mass tort funding market through a diversified portfolio approach.
Through a portfolio of equity investments in targeted mass tort cases with varied duration and case-type, and at different points in the litigation lifecycle, our investment approach seeks to provide investors with diversification, while maximizing return velocity and offering compelling risk-adjusted return potential.
Self-liquidating structure and legal-outcome driven returns. Uncorrelated to traditional markets.
Exposure across tort types, jurisdiction, law firm and investment types minimize single-case risk.
Benefit from our partner's data-driven approach to sourcing, underwriting, and monitoring investments.
Support access to justice for claimants while generating attractive returns for investors.
Litigation funding is an alternative investment strategy in which capital is deployed to fund legal claims. The strategy employed by the Fund focuses on mass tort litigation, where capital is used to support the acquisition and advancement of claimants on behalf of established law firms. In return, the Fund participates in a portion of the law firm’s contingent legal fees, which are realized only upon successful case resolution and settlement.
This offers investors uncorrelated, impact-oriented returns outside traditional markets, while supporting claimants' pursuit of justice.
A mass tort involves many plaintiffs filing individual claims against a common defendant for related harm (e.g., defective drugs), with each case evaluated and compensated based on its specific facts. In contrast, a class action is a single lawsuit representing a group of similarly affected individuals, with outcomes and settlements applied broadly across the class.
Mass torts allow for individualized damages and greater plaintiff involvement, while class actions streamline litigation but typically result in standardized compensation distributed among all class members.
Reform Capital is a strategic partner focused on sourcing and evaluating mass tort investment opportunities with deep expertise in the litigation ecosystem.
Through deep relationships across leading plaintiff law firms, marketing firms, and other participants in the mass tort ecosystem, Reform Capital helps identify, diligence, and monitor investment opportunities for the Fund.
Through its integration with Handled Technology, Reform Capital benefits from unique visibility into operational trends and performance data across the mass torts, including intake conversion, fallout patterns, settlement velocity, and acquisition-cost effectiveness. These insights support a data-driven approach to sourcing, underwriting, and ongoing portfolio monitoring.
For accredited investors interested in direct exposure to the mass tort market.
Are you an Accredited Investor? The sale of this product is restricted to Accredited Investors. Only Accredited Investors are permitted to access this site and place an order for this product. There are a number of ways investors may qualify as an Accredited Investor.
Consult with your Investment Advisor to determine if you qualify.
